⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19460482 | 1.00 | — | — | |
| SCHEMBL29787406 | 1.00 | — | — | |
| SCHEMBL2554678 | 0.97 | CA2 (0.37) | — | |
| Hydrochloric Acid SCHEMBL622578 | 0.97 | — | — | |
| Trifluoroacetic Acid SCHEMBL27848923 | 0.80 | DPP8 (0.39) | — | |
| SCHEMBL19641926 | 0.78 | CA1 (0.38) | — | |
| SCHEMBL222996 | 0.77 | — | — | |
| SCHEMBL22021519 | 0.77 | — | — | |
| SCHEMBL22811253 | 0.77 | — | — | |
| SCHEMBL4782993 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1033 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4702014-A1 | BIFUNCTIONAL COMPOUNDS FOR DEGRADING BRAF VIA UBIQUITIN PROTEOSOME PATHWAY | Nurix Therapeutics, Inc. (US) | 2026-03-04 | — | — | EP | claimed |
| EP-4073044-B1 | NEW BRAF INHIBITORS AS PARADOX BREAKERS | HOFFMANN LA ROCHE (CH) | 2025-02-19 | — | — | EP | claimed |
| WO-2024227104-A1 | BIFUNCTIONAL COMPOUNDS FOR DEGRADING BRAF VIA UBIQUITIN PROTEOSOME PATHWAY | NURIX THERAPEUTICS, INC. (US) | 2024-10-31 | — | — | WO | claimed |
| CN-108137545-A | TRIAZOLE AGONISTS OF THE APJ RECEPTOR | 美国安进公司 | 2018-06-08 | — | — | CN | claimed |
| CN-108069976-A | A kind of nitrogenous macrocyclic compounds, its preparation method, pharmaceutical composition and application | 山东罗欣药业集团股份有限公司 | 2018-05-25 | — | — | CN | claimed |
| CN-103911615-B | Etching agent composite for copper-containing metal | 东友精细化工有限公司 | 2017-08-22 | — | — | CN | claimed |
| CN-106986862-A | Hepatitis c inhibitor and application thereof | ABBVIE 公司 | 2017-07-28 | — | — | CN | claimed |
| CN-106536488-A | Quinoxaline compound, method for producing the same, and use thereof | 财团法人生物技术开发中心 | 2017-03-22 | — | — | CN | claimed |
| CN-102585242-B | Method for preparing short-chain fatty acid vinyl ester series cement dispersant | UNIV BEIJING TECHNOLOGY | 2013-05-22 | — | — | CN | claimed |
| US-7312200-B2 | 9-ketospinosyn derivatives | BAYER CROPSCIENCE AG (DE) | 2007-12-25 | — | — | US | claimed |
| US-20060128642-A1 | 9-Ketospinosyn derivatives | BAYER CROPSCIENCE AG (DE) | 2006-06-15 | — | — | US | claimed |
| EP-1590358-A1 | 9-KETOSPINOSYN DERIVATIVES | Bayer CropScience Aktiengesellschaft (DE) | 2005-11-02 | — | — | EP | claimed |
| WO-2004065402-A1 | 9-KETOSPINOSYN DERIVATIVES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2004-08-05 | — | — | WO | claimed |
| EP-0025764-A1 | Process for the preparation of aliphatic sulfonamides | COMPAGNIE FRANCAISE DE RAFFINAGE Société anonyme dite: (FR) | 1981-03-25 | — | — | EP | claimed |
| US-12637432-B2 | Inhibitors of ACK1/TNK2 tyrosine kinase | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) | 2026-05-26 | — | — | US | disclosed |
| US-20260109711-A1 | MACROCYCLIC SULFONAMIDE MODULATORS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2026-04-23 | — | — | US | disclosed |
| EP-4263518-B1 | NEW QUINAZOLINONE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2026-04-01 | — | — | EP | disclosed |
| EP-0025764-A1 | Process for the preparation of aliphatic sulfonamides | COMPAGNIE FRANCAISE DE RAFFINAGE Société anonyme dite: (FR) | 1981-03-25 | — | — | EP | disclosed |
| US-4101541-A | DYES FOR POLYESTERS OR POLYPROPYLENE | CIBA-GEIGY CORPORATION (US) | 1978-07-18 | — | — | US | disclosed |
| US-3935199-A | ANALEPTIC | MEAD JOHNSON & COMPANY (US) | 1976-01-27 | — | — | US | disclosed |